HCM
MBOT icon

Heights Capital Management’s Microbot Medical MBOT Stock Holding History

Heights Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-883,104
Closed -$2.69M – 206
2025
Q3 		$2.69M Buy
+883,104
New +$2.75M 0.77% 25

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Heights Capital Management's MBOT Position: Q4 2025 in Review

Heights Capital Management sold out of Microbot Medical (MBOT) in Q4 2025, closing a stake of 883,104 shares — an estimated $2.69M sold.

Heights Capital Management first reported a position in MBOT in Q3 2025 and held it in 1 quarter. The position peaked at $2.69M in Q3 2025. 70 funds tracked by Wall St. Rank hold MBOT as of Q4 2025.

  • Heights Capital Management reported no remaining Microbot Medical position as of Q4 2025 after selling out during the quarter.
  • Heights Capital Management sold 883,104 Microbot Medical shares in Q4 2025, an estimated $2.69M.
  • Heights Capital Management first reported a position in Microbot Medical in Q3 2025 and held it in 1 quarter.
  • Heights Capital Management's Microbot Medical position peaked at $2.69M in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Microbot Medical as of Q4 2025.

Based on Heights Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.